We are live on ! Find out more
LFST icon

Lifestance Health

133 hedge funds and large institutions have $1.61B invested in Lifestance Health in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 49 increasing their positions, 27 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 27

42% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 26

7% more funds holding

Funds holding: 124133 (+9)

1.18% more ownership

Funds ownership: 84.39%85.57% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

19% less capital invested

Capital invested by funds: $1.98B → $1.61B (-$376M)

27% less call options, than puts

Call options by funds: $3.8M | Put options by funds: $5.19M

Holders
133
Holders Change
+9
Holders Change %
+7.26%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
37
Increased
49
Reduced
27
Closed
26
Calls
$3.8M
Puts
$5.19M
Net Calls
-$1.39M
Net Calls Change
+$4.89M
Name Holding Trade Value Shares
Change
Change in
Stake
GI
126
GAMMA Investing
California
$511 +$470 +78 +300%
EWA
127
EverSource Wealth Advisors
Alabama
$375 -$645 -107 -61%
RIL
128
Rothschild Investment LLC
Illinois
$196 +$121 +20 +100%
DPW
129
DiNuzzo Private Wealth
Pennsylvania
$79 +$18 +3 +23%
JWA
130
JFS Wealth Advisors
Pennsylvania
$40
SIC
131
SJS Investment Consulting
Ohio
$40
Voloridge Investment Management
132
Voloridge Investment Management
Florida
-$1.89M -306,520 Closed
Mirae Asset Global Investments
133
Mirae Asset Global Investments
South Korea
-$1.32M -184,190 Closed
ECM
134
ExodusPoint Capital Management
New York
-$980K -158,823 Closed
Two Sigma Investments
135
Two Sigma Investments
New York
-$975K -158,090 Closed
Marshall Wace
136
Marshall Wace
United Kingdom
-$754K -122,243 Closed
GCP
137
GSA Capital Partners
United Kingdom
-$429K -69,492 Closed
CSS
138
Cubist Systematic Strategies
Connecticut
-$420K -68,111 Closed
NYLIM
139
New York Life Investment Management
New York
-$370K -59,930 Closed
AIG
140
American International Group
New York
-$323K -52,307 Closed
BCM
141
Bayesian Capital Management
New York
-$238K -38,600 Closed
AQR Capital Management
142
AQR Capital Management
Connecticut
-$193K -31,334 Closed
JF
143
Jump Financial
Illinois
-$148K -24,009 Closed
VF
144
Virtu Financial
New York
-$106K -17,108 Closed
HighTower Advisors
145
HighTower Advisors
Illinois
-$100K -16,156 Closed
OQS
146
Occudo Quantitative Strategies
Florida
-$84.6K -13,713 Closed
AIM
147
Allen Investment Management
New York
-$79.4K -12,873 Closed
ACM
148
Aquatic Capital Management
Illinois
-$79K -12,800 Closed
MLICM
149
Metropolitan Life Insurance Company (MetLife)
New York
-$35.5K -5,749 Closed
DekaBank Deutsche Girozentrale
150
DekaBank Deutsche Girozentrale
Germany
-$31K -4,957 Closed

LFST Hedge Fund Activity: Q2 2024 in Review

133 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q2 2024, worth a combined $1.61B — down 19% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new LFST positions and 26 closed out — a net gain of 11 holders — while 49 added to existing stakes and 27 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $41.9M. The largest seller was TPG GP A, cutting an estimated $87.9M.

  • 133 institutional investors held Lifestance Health (LFST) as of Q2 2024, up from 124 in Q1 2024.
  • Funds reported $1.61B of Lifestance Health stock for Q2 2024, down 19% quarter-over-quarter.
  • 37 funds opened new Lifestance Health positions in Q2 2024 and 26 closed out, a net change of +11 holders.
  • The largest Lifestance Health buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $41.9M added.
  • The largest Lifestance Health seller in Q2 2024 was TPG GP A, an estimated $87.9M sold.

Based on aggregated 13F filings for Q2 2024.